Daily Sepsis Research Analysis
Analyzed 7 papers and selected 3 impactful papers.
Summary
Three studies advance understanding and management of sepsis-related conditions across the peripartum and neonatal domains. A Mendelian randomization analysis implicates specific gut microbes and immune-cell phenotypes in puerperal sepsis risk, while an East African meta-analysis quantifies high neonatal surgical mortality and highlights sepsis prevention priorities. A network meta-analysis in very-low-birthweight infants suggests a rapid-increase TPN strategy may offer favorable efficacy with lower sepsis proportions than other regimens.
Research Themes
- Microbiome–immune mediation in puerperal sepsis
- Neonatal surgical mortality and sepsis prevention in LMICs
- Parenteral nutrition dosing and sepsis risk in VLBW infants
Selected Articles
1. The Mediating Role of Immune Cells in the Genetically Predicted Relationship between Gut Microbiota and Puerperal Sepsis: A Mendelian Randomization Study.
Using large-scale GWAS instruments, this MR study supports a causal contribution of 11 gut taxa to puerperal sepsis risk and identifies partial mediation via IgD−CD27− B cells and CD62L− monocytes. Reverse causality was excluded, strengthening causal inference. The findings nominate microbial and immune-cell biomarkers and potential targets for risk stratification.
Impact: This is a methodologically rigorous genetic causal analysis that advances mechanistic understanding of puerperal sepsis and proposes testable immune-mediated pathways. It opens avenues for biomarker development and microbiome-targeted prevention.
Clinical Implications: While not practice-changing yet, results suggest prioritizing studies that integrate microbiome profiling and immune phenotyping in postpartum infections and exploring microbiome modulation to reduce puerperal sepsis risk.
Key Findings
- Eleven gut microbiota taxa showed a causal relationship with puerperal sepsis across MR models.
- Reverse MR excluded causal effects from puerperal sepsis to gut microbiota, reducing reverse causation concerns.
- Two-step mediation MR indicated partial mediation by IgD−CD27− B cells (10.26%) and CD62L− monocytes (17.29%) for CAG-245 sp000435175.
Methodological Strengths
- Use of large-scale GWAS with multiple MR sensitivity analyses to address pleiotropy and heterogeneity
- Two-step mediation MR dissecting immune-cell pathways and reverse MR to test directionality
Limitations
- MR infers causality from genetic instruments and lacks direct clinical intervention validation
- Specific cohort ancestries and exact sample sizes are not detailed here, potentially limiting generalizability
Future Directions: Prospective studies integrating microbiome sequencing and immune phenotyping in postpartum cohorts, and interventional trials modulating implicated taxa to test risk reduction.
BACKGROUND: The causal relationship between gut microbiota and puerperal sepsis (PS) remains unclear, and there is a lack of in-depth research regarding the potential mediating role of immune cells in this context. OBJECTIVE: This study aims to investigate the causal relationship between gut microbiota and PS using Mendelian randomization (MR) analysis and to assess the mediating effects of immune cells on the risk of PS onset through mediation analysis. MATERIALS AND METHODS: We selected data from large-scale genome-wide association studies (GWAS) involving 473 gut microbiota species, 731 immune cell phenotypes, and PS datasets. Univariate MR (UVMR) analysis was employed to explore the causal relationship between gut microbiota and PS, with the primary statistical method being inverse variance weighting (IVW). Multiple statistical models were applied for sensitivity analysis to minimize the confounding effects of horizontal pleiotropy and heterogeneity. Subsequently, a two-step mediation MR analysis was conducted to evaluate whether immune cells mediate the relationship between gut microbiota and PS. RESULTS AND DISCUSSION: Analysis using various statistical models indicated that 11 gut microbiota species (e.g., Azorhizobiume, Bacillus velezensis, CAG-245 sp000435175, Lentimicrobiaceae, and Providencia) exhibited a causal relationship with PS. Further reverse causal analysis between PS and gut microbiota ruled out the possibility of reverse causality. The two-step mediation MR analysis demonstrated that the percentage of IgD-CD27- B cells (10.26%) and CD62L- monocytes (17.29%) partially mediated the effect of CAG-245 sp000435175 on PS risk. CONCLUSION: This study provides evidence of a causal relationship between the abundance of certain gut microbiota species and PS, while also revealing a potential mediating role of immune cells. These findings offer valuable theoretical insights into personalized treatment strategies and the development of novel diagnostic biomarkers for PS.
2. Neonatal Surgical Mortality in East Africa: A Systematic Review and Meta-Analysis.
Across 12 observational studies including 3,451 neonates in East Africa, the pooled neonatal surgical mortality was 25.7% (95% CI 20.3–31.2). The authors call for targeted interventions—particularly sepsis prevention, thermoregulation protocols, and strengthened referral systems—and for regional registries to inform quality improvement.
Impact: Provides robust regional estimates of neonatal surgical mortality and prioritizes actionable areas such as sepsis prevention in LMIC settings. This synthesis can guide policy and resource allocation.
Clinical Implications: Implement standardized perioperative sepsis bundles, thermoregulation, and referral pathways; develop registries to monitor outcomes and benchmark care across facilities.
Key Findings
- Pooled neonatal surgical mortality in East Africa was 25.7% (95% CI 20.3–31.2).
- Heterogeneity across countries suggests system-level gaps in infrastructure and perioperative care.
- Sepsis prevention, thermoregulation protocols, and strengthened referral systems were identified as priority interventions.
Methodological Strengths
- PRISMA-compliant systematic search across multiple databases
- Risk of bias assessment (Newcastle–Ottawa Scale) and random-effects meta-analysis
Limitations
- Synthesis based on observational studies with likely heterogeneity across settings
- Incomplete reporting of some predictors and potential publication bias
Future Directions: Establish regional neonatal surgical registries, evaluate standardized sepsis bundles prospectively, and invest in perioperative capacity building in LMIC hospitals.
INTRODUCTION: Neonatal surgical conditions contribute significantly to under-five mortality, particularly in low- and middle-income countries (LMICs). However, comprehensive data on neonatal surgical mortality (NSM) and its determinants in East Africa remain scarce. This systematic review and meta-analysis aimed to estimate the pooled mortality rate among neonates with surgical conditions and identify key predictors of mortality in the region. METHODS: Following PRISMA guidelines, we searched PubMed, Scopus, EMBASE, and Google Scholar from inception to 30 June 2025. Observational studies from East Africa reporting mortality in neonates (0-28 days) with surgical conditions, regardless of operation status, were included. Data were extracted using a standardized form, and risk of bias was assessed using the Newcastle-Ottawa Scale. Random-effects meta-analysis was performed to estimate pooled mortality rates. Predictors of mortality were synthesized narratively and via meta-regression where possible. RESULTS: Twelve studies (n=3,451 neonates) from five East African countries were included. The pooled overall mortality rate was 25.7% (95% CI: 20.3-31.2%; I CONCLUSION: Neonatal surgical mortality in East Africa is high, with nearly 1 in 4 neonates with surgical conditions dying. Disparities across countries may highlight systemic gaps in infrastructure, timely access, and perioperative care. Targeted interventions-such as sepsis prevention, thermoregulation protocols, and strengthened referral systems-are urgently needed to reduce mortality. Standardized regional registries and investment in neonatal surgical capacity are critical for equitable care.
3. Different Dosing Strategies of Total Parenteral Nutrition in Very Low Birth Weight Infants: A Network Meta-Analysis of Randomized Controlled Trials.
Across nine RCTs, the rapid-increase TPN strategy shortened time to regain birth weight versus aggressive or standard strategies and showed the lowest proportions of mortality, retinopathy of prematurity, and sepsis, though PDA proportion was higher. Evidence suggests a favorable efficacy–safety balance but remains limited by study number and precision.
Impact: Synthesizes randomized evidence to inform TPN dosing decisions in VLBW infants with implications for sepsis risk mitigation and growth outcomes.
Clinical Implications: Consider a rapid-increase TPN protocol (standard start with faster escalation) while monitoring for PDA; align NICU protocols with emerging evidence and evaluate local outcomes.
Key Findings
- Rapid-increase TPN reduced time to regain birth weight versus aggressive/standard strategies (MD −1.43 days; 95% CI −2.82 to −0.05; P-score 0.80).
- Rapid-increase had the lowest proportions of mortality (0.043), retinopathy (0.124), and sepsis (0.141) among strategies.
- Higher proportion of patent ductus arteriosus (0.508) observed with rapid-increase TPN.
Methodological Strengths
- PRISMA-compliant network meta-analysis integrating nine randomized controlled trials
- Comprehensive multi-database search and frequentist network modeling
Limitations
- Only nine trials with variable precision; some outcomes reported as proportions without direct head-to-head significance testing
- Potential inconsistency and limited long-term developmental/metabolic outcome data
Future Directions: Conduct larger, harmonized RCTs with long-term follow-up to confirm efficacy, sepsis outcomes, and PDA risk, and assess developmental/metabolic sequelae.
INTRODUCTION: Total parenteral nutrition (TPN) is essential for growth in very-low-birthweight (VLBW) infants. The worldwide variation in TPN dosing strategies warrants investigation. This study compared clinical outcomes of aggressive, rapid-increase, and standard TPN dosing strategies in VLBW infants. METHODS: A systematic review and network meta-analysis were conducted following the PRISMA NMA guideline. Searches were performed in PubMed, Scopus, Web of Science, CINAHL, CENTRAL, and ProQuest. Dosing strategies were classified as aggressive (higher starting dose), rapid-increase (standard start with rapid escalation), and standard (NICE-based). Outcomes were analyzed using a Frequentist model in RStudio v4.4.1. RESULTS: Nine randomized controlled trials were included. Compared with aggressive and standard strategies, the rapid-increase strategy was associated with a shorter time to regain birth weight (MD = -1.43 days; 95% CI -2.82 to -0.05; P-score = 0.80). The rapid-increase strategy was also associated with a shorter length of hospitalization (MD = -0.38 days; 95% CI -6.56 to 5.80; P-score = 0.54). Regarding safety outcomes, the rapid-increase strategy had the lowest proportions of mortality (Prop = 0.043), retinopathy (Prop = 0.124), and sepsis (Prop = 0.141), but a higher proportion of patent ductus arteriosus (PDA) (Prop = 0.508). DISCUSSION: The rapid-increase approach demonstrated the most favorable balance between efficacy and safety outcomes among the included trials, although the small number of studies is a limitation. CONCLUSION: Rapid-increase TPN, using the recommended starting dose but achieving maintenance more quickly, may offer clinical advantages for VLBW infants. Further long-term studies are needed to confirm developmental and metabolic impacts.